サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1412926

医療用マリファナ市場：投与経路、用途、流通チャネル別 - 世界予測、2024年～2030年

Medical Marijuana Market by Route of Administration (Inhalation, Oral, Topical), Application (Anorexia, Arthritis, Migraine), Distribution Channel - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 186 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
医療用マリファナ市場：投与経路、用途、流通チャネル別 - 世界予測、2024年～2030年
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医療用マリファナ市場規模は2023年に142億4,000万米ドルと推計され、2024年には156億6,000万米ドルに達し、CAGR 9.07%で2030年には261億6,000万米ドルに達すると予測されます。

医療用マリファナの世界市場

主な市場の統計
基準年[2023年］ 142億4,000万米ドル
予測年[2024年］ 156億6,000万米ドル
予測年 [2030年] 261億6,000万米ドル
CAGR（%） 9.07%
医療用マリファナ Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは医療用マリファナ市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、医療用マリファナ市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-医療用マリファナ市場の市場規模および予測は？

2-医療用マリファナ市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-医療用マリファナ市場における技術動向と規制の枠組みは？

4-医療用マリファナ市場における主要ベンダーの市場シェアは？

5-医療用マリファナ市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 慢性疾患の治療における医療用マリファナの採用の増加
      • 各国における医療用マリファナの合法化
      • 医療用マリファナの利点についての認識の向上
    • 抑制要因
      • アジアおよびアフリカのいくつかの国では合法化されていないため、マリファナの市場アクセスが低下している
    • 機会
      • 特定の国における有利な償還環境
      • 研究開発および臨床試験活動の増加
    • 課題
      • マリファナの用量と医療的性質についての認識の欠如
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 医療用マリファナ市場：投与経路別

  • 吸入
  • 経口
  • 局所

第7章 医療用マリファナ市場：用途別

  • 拒食症
  • 関節炎
  • 片頭痛
  • 筋肉のけいれん
  • 吐き気
  • 疼痛管理
    • がんの痛み
    • 神経因性疼痛
  • 発作

第8章 医療用マリファナ市場：流通チャネル別

  • 薬局
  • オンライン

第9章 南北アメリカの医療用マリファナ市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋の医療用マリファナ市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの医療用マリファナ市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Acreage Holdings
    • Aurora Cannabis Inc.
    • Babylon Sciences SA
    • Canopy Growth Corporation
    • Emerald Health Therapeutics Inc.
    • GBSciences Inc.
    • Jazz Pharmaceuticals, Inc.
    • Lexaria Bioscience Corp.
    • LivWell Enlightened Health LLC
    • Maricann Inc.
    • MediPharm Labs
    • Tikun Olam, Ltd.
    • Tilray
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. MEDICAL MARIJUANA MARKET RESEARCH PROCESS
  • FIGURE 2. MEDICAL MARIJUANA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. MEDICAL MARIJUANA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. MEDICAL MARIJUANA MARKET DYNAMICS
  • FIGURE 7. MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 8. MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 12. MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS MEDICAL MARIJUANA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS MEDICAL MARIJUANA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MEDICAL MARIJUANA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MEDICAL MARIJUANA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. MEDICAL MARIJUANA MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. MEDICAL MARIJUANA MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. MEDICAL MARIJUANA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. MEDICAL MARIJUANA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 6. MEDICAL MARIJUANA MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. MEDICAL MARIJUANA MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. MEDICAL MARIJUANA MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 10. MEDICAL MARIJUANA MARKET SIZE, BY ANOREXIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. MEDICAL MARIJUANA MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. MEDICAL MARIJUANA MARKET SIZE, BY MIGRAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. MEDICAL MARIJUANA MARKET SIZE, BY MUSCLE SPASMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. MEDICAL MARIJUANA MARKET SIZE, BY NAUSEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 17. MEDICAL MARIJUANA MARKET SIZE, BY CANCER PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. MEDICAL MARIJUANA MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. MEDICAL MARIJUANA MARKET SIZE, BY SEIZURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 21. MEDICAL MARIJUANA MARKET SIZE, BY DISPENSARIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. MEDICAL MARIJUANA MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS MEDICAL MARIJUANA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA MEDICAL MARIJUANA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. MEDICAL MARIJUANA MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 192. MEDICAL MARIJUANA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. MEDICAL MARIJUANA MARKET LICENSE & PRICING
目次
Product Code: MRR-AD36CD89826F

[186 Pages Report] The Medical Marijuana Market size was estimated at USD 14.24 billion in 2023 and expected to reach USD 15.66 billion in 2024, at a CAGR 9.07% to reach USD 26.16 billion by 2030.

Global Medical Marijuana Market

KEY MARKET STATISTICS
Base Year [2023] USD 14.24 billion
Estimated Year [2024] USD 15.66 billion
Forecast Year [2030] USD 26.16 billion
CAGR (%) 9.07%
Medical Marijuana Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Medical Marijuana Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Medical Marijuana Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Medical Marijuana Market, highlighting leading vendors and their innovative profiles. These include Acreage Holdings, Aurora Cannabis Inc., Babylon Sciences SA, Canopy Growth Corporation, Emerald Health Therapeutics Inc., GBSciences Inc., Jazz Pharmaceuticals, Inc., Lexaria Bioscience Corp., LivWell Enlightened Health LLC, Maricann Inc., MediPharm Labs, Tikun Olam, Ltd., and Tilray.

Market Segmentation & Coverage

This research report categorizes the Medical Marijuana Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Route of Administration
    • Inhalation
    • Oral
    • Topical
  • Application
    • Anorexia
    • Arthritis
    • Migraine
    • Muscle Spasms
    • Nausea
    • Pain Management
      • Cancer Pain
      • Neuropathic pain
    • Seizures
  • Distribution Channel
    • Dispensaries
    • Online
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Medical Marijuana Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Medical Marijuana Market?

3. What are the technology trends and regulatory frameworks in the Medical Marijuana Market?

4. What is the market share of the leading vendors in the Medical Marijuana Market?

5. Which modes and strategic moves are suitable for entering the Medical Marijuana Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Medical Marijuana Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing adoption of medical marijuana for treatment of chronic diseases
      • 5.1.1.2. Legalization of medical marijuana in various countries
      • 5.1.1.3. Increasing awareness about the benefits of medical marijuana
    • 5.1.2. Restraints
      • 5.1.2.1. Lower market access of marijuana due to absence of legalization in several Asian and African countries
    • 5.1.3. Opportunities
      • 5.1.3.1. Favorable reimbursement environment in certain countries
      • 5.1.3.2. Rising number of research & development and clinical trial activities
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness about dosage and medical properties of marijuana
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Medical Marijuana Market, by Route of Administration

  • 6.1. Introduction
  • 6.2. Inhalation
  • 6.3. Oral
  • 6.4. Topical

7. Medical Marijuana Market, by Application

  • 7.1. Introduction
  • 7.2. Anorexia
  • 7.3. Arthritis
  • 7.4. Migraine
  • 7.5. Muscle Spasms
  • 7.6. Nausea
  • 7.7. Pain Management
    • 7.8.1. Cancer Pain
    • 7.8.2. Neuropathic pain
  • 7.8. Seizures

8. Medical Marijuana Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Dispensaries
  • 8.3. Online

9. Americas Medical Marijuana Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Medical Marijuana Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Medical Marijuana Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Acreage Holdings
    • 13.1.2. Aurora Cannabis Inc.
    • 13.1.3. Babylon Sciences SA
    • 13.1.4. Canopy Growth Corporation
    • 13.1.5. Emerald Health Therapeutics Inc.
    • 13.1.6. GBSciences Inc.
    • 13.1.7. Jazz Pharmaceuticals, Inc.
    • 13.1.8. Lexaria Bioscience Corp.
    • 13.1.9. LivWell Enlightened Health LLC
    • 13.1.10. Maricann Inc.
    • 13.1.11. MediPharm Labs
    • 13.1.12. Tikun Olam, Ltd.
    • 13.1.13. Tilray
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing